JP2013194054A5 - - Google Patents

Download PDF

Info

Publication number
JP2013194054A5
JP2013194054A5 JP2013056191A JP2013056191A JP2013194054A5 JP 2013194054 A5 JP2013194054 A5 JP 2013194054A5 JP 2013056191 A JP2013056191 A JP 2013056191A JP 2013056191 A JP2013056191 A JP 2013056191A JP 2013194054 A5 JP2013194054 A5 JP 2013194054A5
Authority
JP
Japan
Prior art keywords
carried out
solution
igg
diafiltration
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013056191A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013194054A (ja
JP6048936B2 (ja
Filing date
Publication date
Priority claimed from ES201230413A external-priority patent/ES2381828B1/es
Application filed filed Critical
Publication of JP2013194054A publication Critical patent/JP2013194054A/ja
Publication of JP2013194054A5 publication Critical patent/JP2013194054A5/ja
Application granted granted Critical
Publication of JP6048936B2 publication Critical patent/JP6048936B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013056191A 2012-03-20 2013-03-19 熱処理を通じてIgG組成物を得るための方法 Active JP6048936B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201230413A ES2381828B1 (es) 2012-03-20 2012-03-20 PROCEDIMIENTO PARA OBTENER UNA COMPOSICION DE IgG MEDIANTE TRATAMIENTO TERMICO
ES201230413 2012-03-20

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016160479A Division JP2016199586A (ja) 2012-03-20 2016-08-18 熱処理を通じてIgG組成物を得るための方法

Publications (3)

Publication Number Publication Date
JP2013194054A JP2013194054A (ja) 2013-09-30
JP2013194054A5 true JP2013194054A5 (enExample) 2014-12-04
JP6048936B2 JP6048936B2 (ja) 2016-12-21

Family

ID=46053016

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013056191A Active JP6048936B2 (ja) 2012-03-20 2013-03-19 熱処理を通じてIgG組成物を得るための方法
JP2016160479A Pending JP2016199586A (ja) 2012-03-20 2016-08-18 熱処理を通じてIgG組成物を得るための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016160479A Pending JP2016199586A (ja) 2012-03-20 2016-08-18 熱処理を通じてIgG組成物を得るための方法

Country Status (21)

Country Link
US (1) US9200032B2 (enExample)
EP (1) EP2641912B1 (enExample)
JP (2) JP6048936B2 (enExample)
KR (1) KR101840064B1 (enExample)
CN (1) CN103319592B (enExample)
AR (1) AR090337A1 (enExample)
AU (1) AU2013201853B2 (enExample)
BR (1) BR102013006411A2 (enExample)
CA (1) CA2809513C (enExample)
CL (1) CL2013000688A1 (enExample)
ES (2) ES2381828B1 (enExample)
HU (1) HUE027915T2 (enExample)
IL (1) IL225197A (enExample)
MX (1) MX339268B (enExample)
MY (1) MY165024A (enExample)
PL (1) PL2641912T3 (enExample)
PT (1) PT2641912T (enExample)
RU (1) RU2636049C2 (enExample)
SG (1) SG193738A1 (enExample)
TW (1) TWI554283B (enExample)
UY (1) UY34679A (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2990033A1 (fr) * 2014-08-26 2016-03-02 Carlina Technologies Procédé de préparation de nanoprécipites de peptide ou protéine de faible poids moléculaire
TR201905974T4 (tr) * 2015-08-31 2019-05-21 Inst Grifols S A İmmünoglobuli̇nleri̇n hazirlanmasi i̇çi̇n yöntem
RU2708394C2 (ru) * 2016-09-26 2019-12-06 Институто Грифольс,С.А. Способ получения иммуноглобулинов
WO2019199476A1 (en) * 2018-04-12 2019-10-17 Amgen Inc. Methods for making stable protein compositions
CN112557643B (zh) * 2019-09-26 2023-04-14 菲鹏生物股份有限公司 变性IgG和类风湿因子免疫抗原及制备方法
CN112858671B (zh) * 2019-11-27 2022-12-27 菲鹏生物股份有限公司 制备类风湿因子检测试剂的方法、类风湿因子检测试剂、试剂盒和检测方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US514375A (en) 1894-02-06 miller
CA1064396A (en) 1975-02-18 1979-10-16 Myer L. Coval Fractional precipitation of gamma globulin with polyethylene glycol
US4165370A (en) 1976-05-21 1979-08-21 Coval M L Injectable gamma globulin
EP0035204B2 (en) 1980-03-05 1991-05-22 Miles Inc. Pasteurized therapeutically active protein compositions
US4396608A (en) 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
ES506679A0 (es) 1981-10-29 1982-08-16 Green Cross Corp Un procedimiento para preparar una immunoglobulina adecuada para inyeccion intravenosa
US4540573A (en) 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
JPH0825902B2 (ja) 1985-02-21 1996-03-13 株式会社ミドリ十字 γ−グロブリンの加熱処理方法
JPH0662436B2 (ja) 1986-05-19 1994-08-17 株式会社ミドリ十字 静注用免疫グロブリン製剤の製造方法
CA1310267C (en) 1986-07-09 1992-11-17 Yutaka Hirao Process for heat treating chemically unmodified _-globulin
JP2547556B2 (ja) 1987-02-06 1996-10-23 株式会社 ミドリ十字 r−グロブリンの液状製剤
US4876241A (en) * 1987-05-22 1989-10-24 Armour Pharmaceutical Company Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants
ES2091161B1 (es) * 1995-04-12 1997-05-16 Grifols Grupo Sa Procedimiento para la produccion de gammaglobulina intramuscular inactivada por pasteurizacion.
AT403989B (de) * 1996-09-16 1998-07-27 Immuno Ag Verfahren zur herstellung eines plasmaprotein-hältigen arzneimittels
US5886154A (en) 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies
UA64742C2 (uk) * 1997-12-24 2004-03-15 Альфа Терапевтик Корпорейшн СПОСІБ ОДЕРЖАННЯ РОЗЧИНУ <font face="Symbol">g</font>-ГЛОБУЛІНУ, ПРИЗНАЧЕНОГО ДЛЯ ВНУТРІШНЬОВЕННОГО ВВЕДЕННЯ, І ПРОДУКТ, ЩО ОДЕРЖУЄТЬСЯ У ЦЕЙ СПОСІБ (ВАРІАНТИ)
ES2421736T3 (es) * 1998-06-09 2013-09-05 Csl Behring Ag Procedimiento para la preparación de inmunoglobulinas para administración intravenosa y otros productos inmunoglobulínicos
PL196770B1 (pl) * 1998-06-09 2008-01-31 Statens Seruminstitut Sposób oczyszczania immunoglobuliny, produkt immunoglobuliny i jego zastosowanie
CN1137727C (zh) * 1998-06-25 2004-02-11 四川远大蜀阳药业有限公司 无保护剂双重病毒灭活制备静注免疫球蛋白工艺
ES2184594B1 (es) 2001-01-17 2004-01-01 Probitas Pharma Sa Procedimiento para la produccion de gammaglobulina g humana inactivada de virus.
WO2005110112A1 (en) * 2004-05-07 2005-11-24 Wisconsin Alumni Research Foundation Methods and compositions involving whey protein isolates
MX2009012786A (es) * 2007-06-01 2009-12-10 Hoffmann La Roche Purificacion de inmunoglobulina.
US8796430B2 (en) * 2010-05-26 2014-08-05 Baxter International Inc. Method to produce an immunoglobulin preparation with improved yield

Similar Documents

Publication Publication Date Title
CN102365368B (zh) 高浓度单克隆抗体溶液中的病毒去除方法
JP2013194054A5 (enExample)
CN105017412B (zh) 一种从牛血清中分离高纯度牛血清白蛋白的方法
CN108350043B (zh) 用于产生肉毒杆菌毒素的方法
JP2011525523A5 (enExample)
RU2013112276A (ru) СПОСОБ ПОЛУЧЕНИЯ КОМПОЗИЦИИ IgG ПОСРЕДСТВОМ ТЕПЛОВОЙ ОБРАБОТКИ
JP2013500711A5 (enExample)
JP7086601B2 (ja) 組換えtnk-tpa(テネクテプラーゼ)の単離及び商業生産のための新規精製方法
MX2019015304A (es) Amortiguador de lavado para cromatografia de intercambio cationico.
CA2757895A1 (en) Method for purifying the rabies virus
JP2014507368A5 (enExample)
ES2780367T3 (es) Nuevo método de purificación eficiente de albumina sérica humana
CN103060294B (zh) 一种能够去除热原及病毒的尿激酶的制备方法
CN1934128A (zh) 在2价阳离子存在下通过加热处理制备人血清白蛋白的方法
US10329323B2 (en) Method for purifying antibodies using PBS
JP6096613B2 (ja) 細胞培養由来のアルファ1プロテアーゼ阻害剤の精製
CN102321591B (zh) 戊型肝炎病毒的病毒样颗粒的组装机制及其制备方法
CN115925890A (zh) 一种抗新冠病毒中和抗体纯化方法
Khazdooz et al. Synthesis of a Cation-Exchange Resin by Inverse Suspension Polymerization for Lactoferrin Extraction from Whey
CN109438585A (zh) 一种b型嗜血杆菌多糖的纯化工艺
US20200131225A1 (en) Methods of purification of albumin fusion proteins
CN104530210A (zh) 一种精制硫酸鱼精蛋白的方法
JP2012112930A (ja) 高分子量物質の精製方法
JP5931363B2 (ja) タンパク質の精製方法
KR101904848B1 (ko) 암 치료용, 접합 치료 백신의 개발용, 및 접종제용으로 사용되는 생물학적으로 안전한 klh 제품의 신규 생성을 위한 제조 방법